SCHEMBL27645166

SCHEMBL27645166

[CH2]c1cccc(-c2cccc(CN)c2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PNMT P11086 1/20 0.47
ENPP2 Q13822 1/20 0.47
LOXL2 Q9Y4K0 2/20 0.46
TAAR1 Q96RJ0 3/20 0.46
CFD P00746 5/20 0.44
CDK8 P49336 1/20 0.44
NOS3 P29474 1/20 0.42
NOS1 P29475 1/20 0.42
NOS2 P35228 1/20 0.42
AGXT P21549 1/20 0.41
HRH3 Q9Y5N1 1/20 0.41
FGFR1 P11362 1/20 0.40
FGFR2 P21802 1/20 0.40
FGFR3 P22607 1/20 0.40
PLG P00747 1/20 0.40
PLAU P00749 1/20 0.40
F11 P03951 1/20 0.40
KLKB1 P03952 1/20 0.40
F7 P08709 1/20 0.40
TPSB2 P20231 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27540046 0.88 TAAR1 (0.61) LOXL2TAAR1HRH3CSNK2A1
SCHEMBL233049 0.87
SCHEMBL3791745 0.87 LOXL2 (0.60) PNMTENPP2LOXL2TAAR1CFD
SCHEMBL27452333 0.86 TAAR1 (0.54) PNMTENPP2LOXL2TAAR1CFD
SCHEMBL27871127 0.85 LOXL2 (0.52) PNMTENPP2LOXL2TAAR1NOS3
SCHEMBL43554 0.80 TAAR1 (0.70) PNMTENPP2LOXL2TAAR1CFD
SCHEMBL3794460 0.80 TAAR1 (0.70) PNMTENPP2LOXL2TAAR1CFD
SCHEMBL29400616 0.80 TAAR1 (0.70) PNMTENPP2LOXL2TAAR1CFD
SCHEMBL5990622 0.79 PRKCI (0.58) ENPP2CDK8FGFR1
Bromide SCHEMBL1856525 0.78 TAAR1 (0.67) PNMTENPP2LOXL2TAAR1CFD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100497345-C 2, 3-dihydro-6-nitroimidazolo [2,1-b] oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2009-06-10 CN disclosed
CN-1878777-A 2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2006-12-13 CN disclosed
CN-1311779-A Succinoylamino lactams as inhibitors and as A beta protein production DU PONT PHARM CO (US) 2001-09-05 CN disclosed